Literature DB >> 1654357

Cryptosporidiosis facilitated by murine retroviral infection with LP-BM5.

H Darban1, J Enriquez, C R Sterling, M C Lopez, G Chen, M Abbaszadegan, R R Watson.   

Abstract

LP-BM5 murine leukemia virus infection caused alterations in splenic T cell subsets in adult C57BL/6 female mice. Prolonged infection resulted in increased immunosuppression and a concomitant decreased resistance to Cryptosporidium parvum infection. Significant Cryptosporidium colonization of the intestinal villi was seen 10 days after oral challenge in mice infected with murine retrovirus for 3 months but not in non-virally infected controls. Parasite numbers per villus of retrovirally infected mice were 20-fold higher than in controls, which showed only occasional parasites. Feces from most virally infected mice but none from controls contained oocysts. Cryptosporidium infection in mice after 4 and 5 months of retroviral infection was accompanied by severe immunosuppression and parasite levels 50-5000 times higher than in controls. A high level of infection persisted 21 days after Cryptosporidium challenge in virally infected mice, while controls cleared their transient and marginal infection. These results further characterize LP-BM5 infection as a murine model of retrovirally induced acquired immune deficiency.

Entities:  

Mesh:

Year:  1991        PMID: 1654357     DOI: 10.1093/infdis/164.4.741

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Citrobacter-induced colitis in mice with murine acquired immunodeficiency syndrome.

Authors:  T N Fredrickson; J W Hartley; H C Morse
Journal:  Vet Pathol       Date:  2010-01-29       Impact factor: 2.221

2.  Apoptosis by CD95 (Fas)-dependent and -independent mechanisms in Peyer's patch lymphocytes in murine retrovirus-induced immunodeficiency syndrome.

Authors:  J Usami; K Hiromatsu; Y Aoki; N Kobayashi; M Makino; H Yagita; Y Matsumoto; K Maeda; Y Yoshikai
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

3.  Cryptococcus neoformans infection in mice previously infected with LP-BM5 MuLV, the agent of murine AIDS (MAIDS).

Authors:  C Lacroix; F Chau; C Carbon; M Sinet; F Derouin
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

4.  Murine AIDS protects mice against experimental cerebral malaria: down-regulation by interleukin 10 of a T-helper type 1 CD4+ cell-mediated pathology.

Authors:  M Eckwalanga; M Marussig; M D Tavares; J C Bouanga; E Hulier; J H Pavlovitch; P Minoprio; D Portnoï; L Rénia; D Mazier
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

5.  Opportunistic infections and retrovirus-induced immunodeficiency: studies of acute and chronic infections with Toxoplasma gondii in mice infected with LP-BM5 murine leukemia viruses.

Authors:  R T Gazzinelli; J W Hartley; T N Fredrickson; S K Chattopadhyay; A Sher; H C Morse
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

6.  Interactions between murine AIDS (MAIDS) and toxoplasmosis in co-infected mice.

Authors:  C Lacroix; M Levacher-Clergeot; F Chau; M H Sumuyen; M Sinet; J J Pocidalo; F Derouin
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

7.  T-cell reconstitution during murine acquired immunodeficiency syndrome (MAIDS) produces neuroinflammation and mortality in animals harboring opportunistic viral brain infection.

Authors:  Manohar B Mutnal; Scott J Schachtele; Shuxian Hu; James R Lokensgard
Journal:  J Neuroinflammation       Date:  2013-07-31       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.